Delivery Order SPE2DB24D1205-SPE2DB25FCXEX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Calquence 100 mg tablets (60-count packages) with a ceiling value of $5,593.77. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 on August 1, 2025, for the supply of Calquence 100 mg tablets (60 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 22, 2025, and performance to be fulfilled at the company's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's broader relationship with DLA, leveraging the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a contract ceiling value of $5,593.77 and an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation, indicating the vendor's capability to meet federal procurement standards through open competition. The contract is performed at...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,187.56 for Calquence 100 mg tablets (60-count units) on August 11, 2025, with completion targeted for September 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Calquence 100 mg tablets in a quantity of 60 units, with a ceiling value of $16,781.31. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for completion by September 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $11,187.56. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitive award with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. This is a competitive, non-set-aside award to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. The delivery order represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The Defense Logistics Agency awarded a $5,593.77 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Calquence 100 mg tablets (60-count units). This non-set-aside, firm fixed-price delivery order is scheduled for completion by August 18, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Calquence 100 mg tablets (60-unit quantity) under a firm fixed-price contract with a ceiling value of $5,593.77. This non-set-aside delivery order is scheduled for completion by September 8, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCXEXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $5,593.77. This firm fixed-price delivery order is set to be completed by June 23, 2025, and represents performance from AmerisourceBergen's Conshohocken, Pennsylvania location. The award is issued under a competitive, non-set-aside procurement mechanism, reflecting AmerisourceBergen's established capability as a major pharmaceutical distributor serving federal medical supply chains. This delivery order operates as a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates extensive experience fulfilling specialized pharmaceutical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 5/30/25 |